aldosterone has been researched along with nimodipine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrisano, V; Barril, X; Bartolini, M; Carreiras, Mdo C; de los Ríos, C; García, AG; Huertas, O; León, R; López, B; López, MG; Luque, FJ; Marco-Contelles, J; Rodríguez-Franco, MI; Samadi, A; Villarroya, M | 1 |
| Borkowski, J; Ducret, T; Gentsch, C; Haeusler, A; Hengerer, B; Lederer, R; Mondadori, C; Racine, A | 1 |
| Kojima, I; Kojima, K; Rasmussen, H | 1 |
| Blinn, JR; Bolten, CW; Dietz, JD; Du, S; Funder, JW; Hu, X; Payne, MA; Xia, C | 1 |
| Brennan, FE; Cheung, CM; Fuller, PJ; Pippal, JB; Yao, YZ | 1 |
| Axelsson, J; Oberg, CM; Rippe, A; Rippe, B | 1 |
6 other study(ies) available for aldosterone and nimodipine
| Article | Year |
|---|---|
Tacripyrines, the first tacrine-dihydropyridine hybrids, as multitarget-directed ligands for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Blood-Brain Barrier; Butyrylcholinesterase; Calcium; Calcium Channel Blockers; Catalytic Domain; Cell Death; Cell Line, Tumor; Cholinesterase Inhibitors; Cytosol; Dihydropyridines; Humans; Hydrogen Peroxide; Kinetics; Ligands; Models, Molecular; Peptide Fragments; Permeability; Tacrine | 2009 |
Pretreatment with aldosterone or corticosterone blocks the memory-enhancing effects of nimodipine, captopril, CGP 37,849, and strychnine in mice.
Topics: 2-Amino-5-phosphonovalerate; Aldosterone; Animals; Avoidance Learning; Captopril; Corticosterone; Darkness; Male; Memory; Mice; Nimodipine; Receptors, N-Methyl-D-Aspartate; Strychnine | 1992 |
Dihydropyridine calcium agonist and antagonist effects on aldosterone secretion.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenal Glands; Aldosterone; Angiotensin II; Animals; Calcium; Calcium Channel Blockers; Cattle; Cells, Cultured; Dantrolene; Ion Channels; Nicotinic Acids; Nifedipine; Nimodipine; Nisoldipine; Nitrendipine; Potassium; Stimulation, Chemical | 1984 |
A number of marketed dihydropyridine calcium channel blockers have mineralocorticoid receptor antagonist activity.
Topics: Adrenalectomy; Aldosterone; Animals; Calcium Channel Blockers; Dihydropyridines; Dose-Response Relationship, Drug; Epithelial Sodium Channels; Male; Mineralocorticoid Receptor Antagonists; Models, Molecular; Mutation; Nimodipine; Protein Binding; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Mineralocorticoid | 2008 |
Characterization of the zebrafish (Danio rerio) mineralocorticoid receptor.
Topics: Aldosterone; Amino Acid Sequence; Animals; Antihypertensive Agents; Cell Line; Desoxycorticosterone; Humans; Hydrocortisone; Mineralocorticoid Receptor Antagonists; Molecular Sequence Data; Nimodipine; Receptors, Mineralocorticoid; Sequence Alignment; Sequence Analysis, DNA; Spironolactone; Transcriptional Activation; Zebrafish | 2011 |
Rapid, dynamic changes in glomerular permeability to macromolecules during systemic angiotensin II (ANG II) infusion in rats.
Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Ficoll; Glomerular Filtration Rate; Infusions, Intravenous; Kidney Glomerulus; Male; Mineralocorticoid Receptor Antagonists; Nimodipine; Permeability; Rats; Rats, Wistar; Spironolactone; Tetrazoles; Vasodilator Agents | 2012 |